Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Cancer. 2010 Aug 16;116(23):5470–5478. doi: 10.1002/cncr.25518

Figure 4.

Figure 4

Time to disease progression is shown. A Kaplan-Meier survival curve indicates the number of days from treatment with low-activity samarium-153 ethylenediamine tetramethylene phosphoric acid until the first evaluation that revealed radiographic evidence of progressive disease. PFS indicates progression-free survival.